03:25 AM EDT, 10/03/2025 (MT Newswires) -- Jacob Chacko, Director, President and Chief Executive Officer, on September 30, 2025, sold 87,539 shares in Oric Pharmaceuticals ( ORIC ) for $1,053,555. Following the Form 4 filing with the SEC, Chacko has control over a total of 568,880 common shares of the company, with 568,880 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1796280/000160893625000008/xslF345X05/form4-10022025_111028.xml